Financhill
Back

Novo Nordisk AS Stock Predictions

Novo Nordisk AS Stock Forecast

  • Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 24.2% based on the past 15 years of stock performance.
  • Novo Nordisk AS has risen higher in 12 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
  • Is Novo Nordisk AS Stock Undervalued?
    The current Novo Nordisk AS [NONOF] share price is $105.00. The Score for NONOF is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Novo Nordisk AS Stock Go Up Next Year?

  • Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 24.2% based on the past 15 years of stock performance.

Novo Nordisk AS Stock Rating

Sell
34
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS overpriced?

  • Novo Nordisk AS has risen higher in 12 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Novo Nordisk AS Stock Price History

Is NONOF stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com

52-Week Data

52-Week High:
149.55
52-Week Low:
94.36

Prediction Charts

Market Cap:
466.54B
Price in USD:
105.00
Volume:
5.88K
Beta:
0.51

Technical Analysis

SMA50:
115.37
SMA100:
124.61
SMA200:
127.70
52-Wk Change:
1.94%

Stock Predictions

  • Is Novo Nordisk AS stock public?
    Yes, Novo Nordisk AS is a publicly traded company.
  • What is the Novo Nordisk AS stock quote today?
    The Novo Nordisk AS stock price is 105.00 USD today.
  • How to buy Novo Nordisk AS stock online?
    You can buy Novo Nordisk AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 110.48 106.21 112.15 105.00
Nov-6 104.35 110.60 112.50 104.35
Nov-7 110.00 106.01 110.25 106.00
Nov-8 102.90 110.70 111.20 102.90
Nov-11 113.23 107.81 113.90 107.80
Nov-12 107.99 105.43 108.84 104.57
Nov-13 104.11 104.81 110.00 103.00
Nov-14 110.90 105.79 110.90 104.26
Nov-15 104.23 102.20 105.00 99.37
Nov-18 102.00 101.21 103.99 98.03
Nov-19 98.75 101.21 105.00 98.75
Nov-20 101.28 105.49 107.00 99.65
Nov-21 105.67 102.84 105.67 100.00
Nov-22 103.00 105.00 106.19 101.70

Novo Nordisk AS Earnings

Novo Nordisk AS Earnings Report: Per Share Novo Nordisk AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Novo Nordisk AS Forecast Revenue Growth

Novo Nordisk AS Stock Analysis: Historical quarterly revenues per share for Novo Nordisk AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.